GL1X · GenesisL1 explorer

MolNFT v1 · #100258 · protein

42F3 TCR PCPB9/H-2LD complex

4MS8 · 42F3 alpha: “42F3 TCR PCPB9/H-2LD complex”. X-ray diffraction, 7 pockets (best druggability 0.75). MolNFT v1 #100258 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4MS8
Type
protein
Length
606 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
42F3 alpha; 42F3 beta; H-2 class I histocompatibility antigen, L-D alpha chain; PCPB9
UniProt
P01897
Pockets
7 · best druggability 0.75

Structure

x-ray diffraction · 4 distinct chains · 16% helix, 44% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
C42F3 alphaprotein1966% helix, 44% strand—
D42F3 betaprotein2397% helix, 53% strand—
AH-2 class I histocompatibility antigen, L-D alpha chainprotein16240% helix, 35% strandP01897
BPCPB9protein90% helix, 0% strand—

Pockets

7 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110080.750.7878empty
21570.620.8424empty
3750.390.7822empty
4670.330.7617empty
5650.290.7418empty

Interfaces

6 interfaces between chains.

  • C–D · 2146 Ų buried · 27 hydrogen bonds · protein-protein
  • A–B · 839 Ų buried · 13 hydrogen bonds · protein-protein
  • C–A · 394 Ų buried · 2 hydrogen bonds · protein-protein
  • D–A · 355 Ų buried · 3 hydrogen bonds · protein-protein
  • D–B · 212 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 4MS8 · 42F3 TCR pCPB9/H-2Ld Complex · the same entry in another collection · chain C against C, TM-score 1.00
  • P01897 · AlphaFold monomer V2.0 prediction for H-2 class I histocompatibility antigen, L-D alpha… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.